SEC Filings

Document Details

Form
Filing Date
Apr 24, 2020
Document Date
Dec 31, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Aimmune Therapeutics
Issuer
Aimmune Therapeutics, Inc.